P. Fromm

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
P D Fromm, Phillip Fromm, Phillip D. Fromm, P. D. Fromm, Phillip Dieter Fromm, P Fromm, Phillip D Fromm
Publication record
65 papers · 1,443 citations · H-index 21

PAPERS

Circulating and Endometrial Regulatory T Cell and Related Populations in Endometriosis and Infertility: Endometriosis Is Associated with Blunting of Endometrial Cyclical Effects and Reduced Proportions in Moderate-Severe Disease
202114 citationsauthor #3
Comprehensive analysis utilizing flow cytometry and immunohistochemistry reveals inflammatory changes in local endometrial and systemic dendritic cell populations in endometriosis.
202020 citationsauthor #4
Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics
20199 citationsauthor #1
On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
201915 citationsauthor #5
Examination of CD302 as a potential therapeutic target for acute myeloid leukemia
201912 citationsauthor #7
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation
20196 citationsauthor #8
Dendritic cells as cancer therapeutics.
201954 citationsauthor #5
Characterization of the New Immune Suppressive Anti Human CD83 Monoclonal Antibody 3C12C in Non-Human Primates
20180 citationsauthor #7
IMMU-50. THE IMMUNE LANDSCAPE OF BLOOD DENDRITIC CELLS IN GLIOBLASTOMA MULTIFORME: IMPLICATIONS FOR DC VACCINATION COMBINED WITH CHECKPOINT INHIBITION
20180 citationsauthor #3
Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damage
201819 citationsauthor #3
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission
201825 citationsauthor #15
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
201823 citationsauthor #15
EXTH-46. A COMBINATORY IMMUNOTHERAPY AGAINST BRAIN TUMOUR: BLOOD DENDRITIC CELL BASED VACCINE THERAPY WITH CHECKPOINT INHIBITOR(S)
20180 citationsauthor #6
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumour T cell responses at remission
20180 citationsauthor #1
of the Radboud University Nijmegen
20170 citationsauthor #6
Early CCR6 expression on B cells modulates germinal centre kinetics and efficient antibody responses
201741 citationsauthor #4
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumour T cell responses at remission
20170 citationsauthor #23
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population
201635 citationsauthor #7
A CD2 high‐expressing stress‐resistant human plasmacytoid dendritic‐cell subset
201635 citationsauthor #2
Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration
201622 citationsauthor #3
CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses
201616 citationsauthor #1
A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia
20163 citationsauthor #3
mRNA Loaded CMRF-56 Blood Dendritic Cells Augment Anti-Cancer Immune Responses in Conjunction with Nivolumab
20161 citationsauthor #2
Blood dendritic cell immunotherapy as consolidation therapy for acute myeloid leukaemia
20160 citationsauthor #2
Characterisation of the tissue distribution and function of the C-type lectin receptor CD302 in humans and mice
20160 citationsauthor #2
CD16+ Dendritic Cells Are a Unique Myeloid Antigen Presenting Cell Population
20164 citationsauthor #1
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
201631 citationsauthor #15
CMRF-56 blood dendritic cell vaccination as consolidation therapy for acute myeloid leukaemia
20160 citationsauthor #3
New insights into the phenotype of human dendritic cell populations
201616 citationsauthor #3
Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response
201631 citationsauthor #1
A multi-laboratory comparison of blood dendritic cell populations
201618 citationsauthor #1
Characterisation of Human CD83 Expression on Immune Cells and Their Targeting with CD83 Antibodies to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation
20150 citationsauthor #6
The Human Monoclonal Antibody 3C12C, Targeting Activated Dendritic Cells Is a Potential New Immunosuppressive Agent
20150 citationsauthor #14
mRNA loaded CMRF-56+ dendritic cells: a novel anti-cancer vaccination strategy (VAC13P.1122)
20150 citationsauthor #11
Human Cd83 Expression On Immune Cells Validates Anti-Cd83 Prophylaxis to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation.
20150 citationsauthor #5
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy
2015148 citationsauthor #7
Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state
201475 citationsauthor #7
Correction: Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
20141 citationsauthor #7
Dendritic cells and impaired immune tolerance in infertility
20141 citationsauthor #5
Anti-cancer vaccination using mRNA-loaded CMRF-56 immunoselected blood dendritic cells
20140 citationsauthor #1
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma
2014103 citationsauthor #9
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
20130 citationsauthor #4
mRNA loading of human blood dendritic cells for anti-cancer vaccination
20130 citationsauthor #1
Long-term survival in multiple myeloma is associated with a distinct immunological profile , which includes proliferative cytotoxic T-cell clones and a favourable Treg / Th 17 balance
201310 citationsauthor #10
CCR6 is transiently upregulated on B cells after activation and modulates the germinal center reaction in the mouse
201336 citationsauthor #2
Generation of killer dendritic cells starting from blood monocytes using interleukin-15: prospects for the use in immunotherapy
20130 citationsauthor #5
Dendritic Cell Activation in Allogeneic Haematopoietic Cell Transplantation: A Promising Target for Diagnosis and Therapy
20130 citationsauthor #4
Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance
2013131 citationsauthor #13
Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance
2013131 citationsauthor #14
A robust flow-cytometric protocol for assessing growth rate of hatchery-reared barramundi Lates calcarifer larvae.
20123 citationsauthor #2
CD86 (cid:1) or HLA-G (cid:1) can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis
20120 citationsauthor #7
Ten Year Survival in Patients with Myeloma Is Characterized by the Persistence of Immunological Control Which Is Detected by Immunological Biomarkers
20120 citationsauthor #8
Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
201253 citationsauthor #6
CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis.
2012102 citationsauthor #7
Loss of TNF Signaling Facilitates the Development of a Novel Ly-6Clow Macrophage Population Permissive for Leishmania major Infection
201221 citationsauthor #1
Redundancy of interleukin-6 in the differentiation of T cell and monocyte subsets during cutaneous leishmaniasis.
20119 citationsauthor #3
Mechanism of Cytotoxicity and Cellular Uptake of Lipophilic Inert Dinuclear Polypyridylruthenium(II) Complexes
201168 citationsauthor #2
Ten Year Survivors of Multiple Myeloma Demonstrate a Differential Expression of Immunological Biomarkers Including a High Incidence of Cytotoxic T-Cell Clones Which Have Not Acquired Myeloma-Associated Anergy,
20111 citationsauthor #8
Cellular therapy to treat haematological and other malignancies: progress and pitfalls
20115 citationsauthor #1
Inside Cover: Mechanism of Cytotoxicity and Cellular Uptake of Lipophilic Inert Dinuclear Polypyridylruthenium(II) Complexes (ChemMedChem 5/2011)
20110 citationsauthor #2
Tumor necrosis factor negative bone marrow‐derived dendritic cells exhibit deficient IL‐10 expression
20106 citationsauthor #3
Dissociation of interferon-gamma production and resistance to leishmaniasis in the absence of tumor necrosis factor
20101 citationsauthor #1
A Versatile High Throughput Screening System for the Simultaneous Identification of Anti-Inflammatory and Neuroprotective Compounds
201026 citationsauthor #5
The role of TNF in parasitic diseases: still more questions than answers.
201055 citationsauthor #4
Age‐dependent, polyclonal hyperactivation of T cells is reduced in TNF‐negative gld/gld mice
20087 citationsauthor #5

TIMELINE

2008 7 citations

2010 88 citations

2011 83 citations

2012 179 citations

2013 177 citations

2014 180 citations

2015 148 citations

2016 212 citations

2017 41 citations

2018 67 citations

2019 96 citations

2020 20 citations

2021 14 citations

COAUTHOR MAP

CONCEPT FOOTPRINT